Exact Mass: 482.2006
Exact Mass Matches: 482.2006
Found 500 metabolites which its exact mass value is equals to given mass value 482.2006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Daphnetoxin
A daphnane-type orthoester diterpene with potential cholesterol-lowering activity, found exclusively in plants of the family Thymelaeaceae.
3'-Hydroxy-T2 Toxin
3-Hydroxy-T2 Toxin is a mycotoxin from Fusarium sporotrichiella poae. It is a metabolite of T2 Toxin. It is a potential cereal contaminant. Mycotoxin from Fusarium sporotrichiella poae. Metabolite of T2 Toxin. Potential cereal contaminant D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
7-Hydroxystaurosporine
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Sodium humate
It is used as a food additive .
Heteroclitin
Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1]. Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1].
heteroclitin D
Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1]. Heteroclitin D is a lignin from Kadsura medicinal plants with anti-liqid peroxidation. Heteroclitin D inhibits L-type calcium channels[1].
11-(6-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-4-chloro-1,3,5-triazin-2-yl)-7,11- diazatricyclo[7.3.1.0<2,7>]trideca-2,4-dien-6-one
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.172 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.173 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.176 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.171
1-<4-O-(2-hydroxy-1-hydroxymethylethyl)-3,5-dimethoxyphenyl>-2-<4-(1-propanol)-3-methoxyphenyl>-propane-1,3-diol|1-[4-O-(2-hydroxy-1-hydroxymethylethyl)-3,5-dimethoxyphenyl]-2-[4-(1-propanol)-3-methoxyphenyl]-propane-1,3-diol
(7R,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,5,3-trimethoxy-8-O-4-neolignan
10-acetoxyvaltrathydrin|10-acetyloxyvaltrate hydrin
1-{(7-hydroxy-5-methoxy-6-[18-(hydroxymethyl)oxiranyl]-16,18-dimethoxyphenoxy)phenyl}-2-(11-methoxyphenyl)ethane|isomoniliformine A
3,5-dimethoxy-4-(2R,3-dihydroxy-3-methylbutoxyl)-3,3-dimethylpyrano-(6,7)-isoflavone|pierreione A
1alpha,6alpha-diacetoxy-5alpha,12alpha,7beta,14beta-tetrahydroxycass-13(15)-en-16,12-olide|neocaesalpin MR
6-O-(8-Hydroxy-2,6-dimethyl-2,6-octadienoyl)(E,E-)-2-(3,4-Dihydroxyphenyl)ethyl beta-D-glucopy-ranoside
4-demethyl bisorbibutenolide|demethylbisorbibutenolide
2-[4-(beta-D-glucopyranosyloxy)-3-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]-2-hydroxyacetic acid|sabphenoside A
(7S,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,3,5-trimethoxy-8-O-4-neolignan
Tyr Thr Ala Glu
Ala Asp Phe Met
Ala Asp Met Phe
Ala Glu Thr Tyr
Ala Glu Tyr Thr
Ala Phe Asp Met
Ala Phe Met Asp
Ala Met Asp Phe
Ala Met Phe Asp
Ala Met Val Tyr
Ala Met Tyr Val
Ala Thr Glu Tyr
Ala Thr Tyr Glu
Ala Val Met Tyr
Ala Val Tyr Met
Ala Tyr Glu Thr
Ala Tyr Met Val
Ala Tyr Thr Glu
Ala Tyr Val Met
Cys Asp Phe Val
Cys Asp Val Phe
Cys Phe Asp Val
Cys Phe Ile Thr
Cys Phe Leu Thr
Cys Phe Thr Ile
Cys Phe Thr Leu
Cys Phe Val Asp
Cys Ile Phe Thr
Cys Ile Thr Phe
Cys Leu Phe Thr
Cys Leu Thr Phe
Cys Pro Thr Tyr
Cys Pro Tyr Thr
Cys Thr Phe Ile
Cys Thr Phe Leu
Cys Thr Ile Phe
Cys Thr Leu Phe
Cys Thr Pro Tyr
Cys Thr Tyr Pro
Cys Val Asp Phe
Cys Val Phe Asp
Cys Val Val Tyr
Cys Val Tyr Val
Cys Tyr Pro Thr
Cys Tyr Thr Pro
Cys Tyr Val Val
Asp Ala Phe Met
Asp Ala Met Phe
Asp Cys Phe Val
Asp Cys Val Phe
Asp Phe Ala Met
Asp Phe Cys Val
Asp Phe Met Ala
Asp Phe Thr Thr
Asp Phe Val Cys
Asp Met Ala Phe
Asp Met Phe Ala
Asp Ser Val Tyr
Asp Ser Tyr Val
Asp Thr Phe Thr
Asp Thr Thr Phe
Asp Val Cys Phe
Asp Val Phe Cys
Asp Val Ser Tyr
Asp Val Tyr Ser
Asp Tyr Ser Val
Asp Tyr Val Ser
Glu Ala Thr Tyr
Glu Ala Tyr Thr
Glu Phe Gly Met
Glu Phe Met Gly
Glu Phe Ser Thr
Glu Phe Thr Ser
Glu Gly Phe Met
Glu Gly Met Phe
Glu His Pro Thr
Glu His Thr Pro
Glu Met Phe Gly
Glu Met Gly Phe
Glu Pro His Thr
Glu Pro Thr His
Glu Ser Phe Thr
Glu Ser Thr Phe
Glu Thr Ala Tyr
Glu Thr Phe Ser
Glu Thr His Pro
Glu Thr Pro His
Glu Thr Ser Phe
Glu Thr Tyr Ala
Glu Tyr Ala Thr
Glu Tyr Thr Ala
Phe Ala Asp Met
Phe Ala Met Asp
Phe Cys Asp Val
Phe Cys Ile Thr
Phe Cys Leu Thr
Phe Cys Thr Ile
Phe Cys Thr Leu
Phe Cys Val Asp
Phe Asp Ala Met
Phe Asp Cys Val
Phe Asp Met Ala
Phe Asp Thr Thr
Phe Asp Val Cys
Phe Glu Gly Met
Phe Glu Met Gly
Phe Glu Ser Thr
Phe Glu Thr Ser
Phe Gly Glu Met
Phe Gly Met Glu
Phe Gly Pro Tyr
Phe Gly Tyr Pro
Phe Ile Cys Thr
Phe Ile Thr Cys
Phe Leu Cys Thr
Phe Leu Thr Cys
Phe Met Ala Asp
Phe Met Asp Ala
Phe Met Glu Gly
Phe Met Gly Glu
Phe Met Ser Val
Phe Met Val Ser
Phe Pro Gly Tyr
Phe Pro Tyr Gly
Phe Ser Glu Thr
Phe Ser Met Val
Phe Ser Thr Glu
Phe Ser Val Met
Phe Thr Cys Ile
Phe Thr Cys Leu
Phe Thr Asp Thr
Phe Thr Glu Ser
Phe Thr Ile Cys
Phe Thr Leu Cys
Phe Thr Ser Glu
Phe Thr Thr Asp
Phe Val Cys Asp
Phe Val Asp Cys
Phe Val Met Ser
Phe Val Ser Met
Phe Tyr Gly Pro
Phe Tyr Pro Gly
Gly Glu Phe Met
Gly Glu Met Phe
Gly Phe Glu Met
Gly Phe Met Glu
Gly Phe Pro Tyr
Gly Phe Tyr Pro
Gly Ile Met Tyr
Gly Ile Tyr Met
Gly Leu Met Tyr
Gly Leu Tyr Met
Gly Met Glu Phe
Gly Met Phe Glu
Gly Met Ile Tyr
Gly Met Leu Tyr
Gly Met Tyr Ile
Gly Met Tyr Leu
Gly Pro Phe Tyr
Gly Pro Tyr Phe
Gly Tyr Phe Pro
Gly Tyr Ile Met
Gly Tyr Leu Met
Gly Tyr Met Ile
Gly Tyr Met Leu
Gly Tyr Pro Phe
His Glu Pro Thr
His Glu Thr Pro
His Pro Glu Thr
His Pro Thr Glu
His Thr Glu Pro
His Thr Pro Glu
Ile Cys Phe Thr
Ile Cys Thr Phe
Ile Phe Cys Thr
Ile Phe Thr Cys
Ile Gly Met Tyr
Ile Gly Tyr Met
Ile Met Gly Tyr
Ile Met Tyr Gly
Ile Thr Cys Phe
Ile Thr Phe Cys
Ile Tyr Gly Met
Ile Tyr Met Gly
Leu Cys Phe Thr
Leu Cys Thr Phe
Leu Phe Cys Thr
Leu Phe Thr Cys
Leu Gly Met Tyr
Leu Gly Tyr Met
Leu Met Gly Tyr
Met Ala Asp Phe
Met Ala Phe Asp
Met Asp Ala Phe
Met Asp Phe Ala
Met Glu Phe Gly
Met Glu Gly Phe
Met Phe Ala Asp
Met Phe Asp Ala
Met Phe Glu Gly
Met Phe Gly Glu
Met Gly Glu Phe
Met Gly Phe Glu
Met Met Thr Thr
Met Thr Met Thr
Met Thr Thr Met
Pro Cys Thr Tyr
Pro Cys Tyr Thr
Pro Glu His Thr
Pro Glu Thr His
Pro Phe Gly Tyr
Pro Phe Tyr Gly
Pro Gly Phe Tyr
Pro Gly Tyr Phe
Pro His Glu Thr
Pro His Thr Glu
Pro Thr Cys Tyr
Pro Thr Glu His
Pro Thr His Glu
Pro Thr Tyr Cys
Pro Tyr Cys Thr
Pro Tyr Phe Gly
Pro Tyr Gly Phe
Pro Tyr Thr Cys
Ser Asp Val Tyr
Ser Asp Tyr Val
Ser Glu Phe Thr
Ser Glu Thr Phe
Ser Phe Glu Thr
Ser Phe Thr Glu
Ser Thr Glu Phe
Ser Thr Phe Glu
Ser Val Asp Tyr
Ser Val Tyr Asp
Ser Tyr Asp Val
Ser Tyr Val Asp
Thr Ala Glu Tyr
Thr Ala Tyr Glu
Thr Cys Pro Tyr
Thr Cys Tyr Pro
Thr Asp Phe Thr
Thr Asp Thr Phe
Thr Glu Ala Tyr
Thr Glu Phe Ser
Thr Glu His Pro
Thr Glu Pro His
Thr Glu Ser Phe
Thr Glu Tyr Ala
Thr Phe Asp Thr
Thr Phe Glu Ser
Thr Phe Ser Glu
Thr Phe Thr Asp
Thr His Glu Pro
Thr His Pro Glu
Thr Met Met Thr
Thr Met Thr Met
Thr Pro Cys Tyr
Thr Pro Glu His
Thr Pro His Glu
Thr Pro Tyr Cys
Thr Ser Glu Phe
Thr Ser Phe Glu
Thr Thr Asp Phe
Thr Thr Phe Asp
Thr Thr Met Met
Thr Tyr Ala Glu
Thr Tyr Cys Pro
Thr Tyr Glu Ala
Thr Tyr Pro Cys
Val Cys Asp Phe
Val Cys Phe Asp
Val Asp Cys Phe
Val Asp Phe Cys
Val Asp Ser Tyr
Val Asp Tyr Ser
Val Phe Cys Asp
Val Phe Asp Cys
Val Ser Asp Tyr
Val Ser Tyr Asp
Val Tyr Asp Ser
Val Tyr Ser Asp
Tyr Ala Glu Thr
Tyr Ala Thr Glu
Tyr Cys Pro Thr
Tyr Cys Thr Pro
Tyr Asp Ser Val
Tyr Asp Val Ser
Tyr Glu Ala Thr
Tyr Glu Thr Ala
Tyr Phe Gly Pro
Tyr Phe Pro Gly
Tyr Gly Phe Pro
Tyr Gly Pro Phe
Tyr Pro Cys Thr
Tyr Pro Phe Gly
Tyr Pro Gly Phe
Tyr Pro Thr Cys
Tyr Ser Asp Val
Tyr Ser Val Asp
Tyr Thr Cys Pro
Tyr Thr Glu Ala
Tyr Thr Pro Cys
Tyr Val Asp Ser
Tyr Val Ser Asp
3'-Hydroxy-T 2
(r)-(-)-5,5,6,6,7,7,8,8-octahydro-3,3-di-t-butyl-1,1-bi-2-naphthol, dipotassium salt
Tilorone dihydrochloride
C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D007155 - Immunologic Factors > D007369 - Interferon Inducers D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents Tilorone dihydrochloride is an orally active interferon (IFN) inducer with broad-spectrum antiviral activities. Tilorone dihydrochloride possesses robust anti-Severe fever with thrombocytopenia syndrome virus (SFTSV) activity in vitro and in vivo through stimulation of host innate immunity. Tilorone dihydrochloride can penetrate the blood-brain barrier to activate HIF in the CNS[1][2][3].Tilorone dihydrochloride exhibits an inhibitory activity with EC50 of 230 nM against Ebola virus (EBOV)[4].
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
Predonine
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
1,1,3,3,3,3-hexamethylindodicarbocyanine perchlorate
(2R,6R,7R)-BENZHYDRYL 7-(4-METHYLBENZAMIDO)-3-METHYLENE-8-OXO-5-OXA-1-AZABICYCLO[4.2.0]OCTANE-2-CARBOXYLATE
1,3-diisocyanato-2-methylbenzene,ethanol,hexanedioic acid,2-hydroxyethyl prop-2-enoate
Cyclopropanecarboxylic acid, 1-[4-[3-methyl-4-[[[(1R)-1-phenylethoxy]carbonyl]amino]-5-isoxazolyl][1,1-biphenyl]-4-yl]-
Pierreione A
A methoxyisoflavone that is isoflavone substituted by methoxy groups at positions 5 and 3, a 2R,3-dihydroxy-3-methylbutoxyl group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
7-Hydroxystaurosporine
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents
3-(4-chloro-6-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1,3,5-triazin-2-yl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
2-[[3-butyl-6-(4-morpholinyl)-4-oxo-2-quinazolinyl]thio]-N-(3-methoxyphenyl)acetamide
Tert-butyl 2-[5-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-4-oxo-2-phenylchromen-7-yl]oxyacetate
N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-oxo-3-pyrrolidinecarboxamide
(2S)-2-[[oxo-[5-[oxo-[(phenylmethyl)amino]methyl]-1H-imidazol-4-yl]methyl]amino]-3-phenylpropanoic acid (phenylmethyl) ester
N-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-2-[(1-ethyl-2-oxo-4-quinolinyl)oxy]acetamide
(2S)-2-[[[4-[(3-methylanilino)-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]-3-phenylpropanoic acid (phenylmethyl) ester
N-(4-chlorobenzyl)-2-((2R,3S,6S,Z)-3,4-dimethyl-5,12-dioxo-2-phenyl-1-oxa-4-azacyclododec-8-en-6-yl)acetamide
(1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-(propan-2-ylcarbamoyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(2S,3S,3aR,9bR)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-1-(1,3-thiazol-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
(1R,9S,10S,11S)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-(propan-2-ylcarbamoyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylic acid
(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-1-(1,3-thiazol-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-methoxy-1-oxoethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N,4-dimethylbenzenesulfonamide
4-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxypentanoate
[(1S,2R,4aR,5S,7R,8S,8aR)-8-[(3aS,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-1,2,3-trihydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-4a-yl]methyl acetate
S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (Z)-oct-6-enethioate
3-Hydroxy-T2 Toxin
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
S-octanoyl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-octanoyl-4-phosphopantetheine; major species at pH 7.3.
4-[(2s,3s)-3-(hydroxymethyl)-5-methoxy-7-[2-(4-methoxyphenyl)ethyl]-2,3-dihydro-1,4-benzodioxin-2-yl]-2,6-dimethoxyphenol
8-(benzoyloxy)-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2,3-dimethyloxirane-2-carboxylate
(1s,12s,13r,14r)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl (2e)-2-methylbut-2-enoate
7-(acetyloxy)-2,5,9-trihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-10-yl acetate
(1s,12r,13s,14s)-19,20-dimethoxy-13,14-dimethyl-18-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,19-pentaen-12-yl (2e)-2-methylbut-2-enoate
(2s,3r,4r,6r)-4-[hydroxy(methyl)amino]-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-16-ol
(5ar,7ar,11as,11bs)-7a,11b-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,12-dihydro-6h-2,5-dioxatetraphene-1,11-dione
5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-9,18-diol
(12r,13s,14s)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl (2z)-2-methylbut-2-enoate
(11r,12s,13s)-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2,4(8),9,16,21-hexaen-11-yl (2z)-2-methylbut-2-enoate
(2s,3r,4r,6r,18r)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaene-16,18-diol
(2s,3s,4s,5s,6r)-5-methoxy-6-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,18-diol
n-[(2s,3r,4r,6r)-3-hydroxy-6-{12-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaen-3-yl}-2-methyloxan-4-yl]ethanimidic acid
4-[3-(hydroxymethyl)-5-methoxy-7-[2-(4-methoxyphenyl)ethyl]-2,3-dihydro-1,4-benzodioxin-2-yl]-2,6-dimethoxyphenol
angeloylgomisin r
{"Ingredient_id": "HBIN016116","Ingredient_name": "angeloylgomisin r","Alias": "NA","Ingredient_formula": "C27H30O8","Ingredient_Smile": "CC=C(C)C(=O)OC1C(C(CC2=CC3=C(C(=C2C4=C(C5=C(C=C14)OCO5)OC)OC)OCO3)C)C","Ingredient_weight": "482.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1210","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44593602","DrugBank_id": "NA"}